Genetic Technologies Limited (GTG.AX)
AUD 0.04
(0.0%)
AUD 0.04
(0.0%)
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 | 3.9 Million AUD | -78.44% |
| 2023 | 18.11 Million AUD | 482.48% |
| 2022 | 3.1 Million AUD | -55.59% |
| 2021 | 7 Million AUD | 0.29% |
| 2020 | 6.98 Million AUD | 12.96% |
| 2019 | 6.18 Million AUD | 15.75% |
| 2018 | 5.33 Million AUD | -36.71% |
| 2017 | 8.43 Million AUD | -1.66% |
| 2016 | 8.57 Million AUD | -7.46% |
| 2015 | 9.27 Million AUD | -16.88% |
| 2014 | 11.15 Million AUD | 5.45% |
| 2013 | 10.57 Million AUD | -30.82% |
| 2012 | 15.28 Million AUD | 0.63% |
| 2011 | 15.19 Million AUD | 3.2% |
| 2010 | 14.72 Million AUD | -27.06% |
| 2009 | 20.18 Million AUD | 20.2% |
| 2008 | 16.79 Million AUD | 91.9% |
| 2007 | 8.74 Million AUD | 9.37% |
| 2006 | 8 Million AUD | -36.61% |
| 2005 | 12.62 Million AUD | 52.98% |
| 2004 | 8.25 Million AUD | -39.29% |
| 2003 | 13.58 Million AUD | -38.19% |
| 2002 | 21.98 Million AUD | 142.56% |
| 2001 | 9.06 Million AUD | 32.83% |
| 2000 | 6.82 Million AUD | 0.0% |
| Year | Operating Expenses | Operating Expenses Growth |
|---|---|---|
| 2024 FY | 8.27 Million AUD | -54.33% |
| 2024 Q4 | 6.26 Million AUD | 0.0% |
| 2024 Q2 | 3.18 Million AUD | 0.0% |
| 2023 FY | 18.11 Million AUD | 482.48% |
| 2023 Q2 | 3.84 Million AUD | 0.0% |
| 2023 Q4 | 3.35 Million AUD | 0.0% |
| 2022 FY | 3.1 Million AUD | -55.59% |
| 2022 Q4 | 7.23 Million AUD | 101.91% |
| 2022 Q1 | 3.1 Million AUD | -18.48% |
| 2022 Q2 | 5.71 Million AUD | 83.78% |
| 2022 Q3 | 3.58 Million AUD | -37.25% |
| 2021 Q3 | 2.49 Million AUD | -40.28% |
| 2021 Q2 | 4.17 Million AUD | 0.0% |
| 2021 Q4 | 3.81 Million AUD | 52.97% |
| 2021 FY | 7 Million AUD | 0.29% |
| 2020 FY | 6.98 Million AUD | 12.96% |
| 2020 Q2 | 2.88 Million AUD | 0.0% |
| 2020 Q4 | 3.92 Million AUD | 0.0% |
| 2019 FY | 6.18 Million AUD | 15.75% |
| 2019 Q4 | 3.11 Million AUD | 0.0% |
| 2019 Q2 | 3.05 Million AUD | 0.0% |
| 2018 Q4 | 2.08 Million AUD | 0.0% |
| 2018 FY | 5.33 Million AUD | -36.71% |
| 2018 Q2 | 3.25 Million AUD | 0.0% |
| 2017 Q2 | 4.17 Million AUD | 0.0% |
| 2017 Q4 | 4.26 Million AUD | 0.0% |
| 2017 FY | 8.43 Million AUD | -1.66% |
| 2016 FY | 8.57 Million AUD | -7.46% |
| 2016 Q4 | 4.17 Million AUD | 0.0% |
| 2016 Q2 | 4.4 Million AUD | 0.0% |
| 2015 Q4 | 4.37 Million AUD | 0.0% |
| 2015 FY | 9.27 Million AUD | -16.88% |
| 2015 Q2 | 4.89 Million AUD | 0.0% |
| 2014 Q4 | 6.1 Million AUD | 0.0% |
| 2014 FY | 11.15 Million AUD | 5.45% |
| 2014 Q2 | 5.04 Million AUD | 0.0% |
| 2013 Q3 | - AUD | -100.0% |
| 2013 Q4 | 5.47 Million AUD | 0.0% |
| 2013 FY | 10.57 Million AUD | -30.82% |
| 2013 Q2 | 3.08 Million AUD | 0.0% |
| 2012 Q3 | - AUD | 0.0% |
| 2012 Q4 | - AUD | 0.0% |
| 2012 FY | 15.28 Million AUD | 0.63% |
| 2012 Q2 | - AUD | 0.0% |
| 2011 Q4 | - AUD | 0.0% |
| 2011 Q2 | - AUD | 0.0% |
| 2011 FY | 15.19 Million AUD | 3.2% |
| 2010 Q4 | - AUD | 0.0% |
| 2010 FY | 14.72 Million AUD | -27.06% |
| 2009 FY | 20.18 Million AUD | 20.2% |
| 2009 Q4 | - AUD | 0.0% |
| 2008 Q4 | -17.68 Million AUD | 0.0% |
| 2008 FY | 16.79 Million AUD | 91.9% |
| 2008 Q1 | - AUD | 100.0% |
| 2008 Q2 | 3.71 Million AUD | 0.0% |
| 2008 Q3 | - AUD | -100.0% |
| 2007 Q4 | -15.31 Million AUD | 0.0% |
| 2007 FY | 8.74 Million AUD | 9.37% |
| 2007 Q3 | - AUD | -100.0% |
| 2007 Q2 | 3.68 Million AUD | 0.0% |
| 2007 Q1 | - AUD | 100.0% |
| 2006 Q4 | -16.06 Million AUD | 0.0% |
| 2006 FY | 8 Million AUD | -36.61% |
| 2006 Q1 | - AUD | 100.0% |
| 2006 Q2 | 4.28 Million AUD | 0.0% |
| 2006 Q3 | - AUD | -100.0% |
| 2005 Q3 | - AUD | -100.0% |
| 2005 Q1 | - AUD | 0.0% |
| 2005 Q4 | -17.23 Million AUD | 0.0% |
| 2005 FY | 12.62 Million AUD | 52.98% |
| 2005 Q2 | 2.46 Million AUD | 0.0% |
| 2004 FY | 8.25 Million AUD | -39.29% |
| 2003 FY | 13.58 Million AUD | -38.19% |
| 2002 FY | 21.98 Million AUD | 142.56% |
| 2001 FY | 9.06 Million AUD | 32.83% |
| 2000 FY | 6.82 Million AUD | 0.0% |
| Name | Operating Expenses | Operating Expenses Difference |
|---|---|---|
| Australian Clinical Labs Limited | 81.54 Million AUD | 95.212% |
| BCAL Diagnostics Limited | 8.54 Million AUD | 54.308% |
| Genetic Signatures Limited | 4.3 Million AUD | 9.367% |
| Healius Limited | 265.1 Million AUD | 98.527% |
| Imagion Biosystems Limited | 15.53 Million AUD | 74.866% |
| Integral Diagnostics Limited | 61.88 Million AUD | 93.691% |
| INOVIQ Ltd | 6.8 Million AUD | 42.639% |
| Microba Life Sciences Limited | 5.9 Million AUD | 33.883% |
| Monash IVF Group Limited | 91.1 Million AUD | 95.715% |
| Rhythm Biosciences Limited | 5.34 Million AUD | 27.017% |
| Sonic Healthcare Limited | 1.49 Billion AUD | 99.739% |